Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials

Lignende værker

• Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain
  af: Ahmedzai, Sam H., et al.
  Udgivet: (2014)
• Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials
  af: Löwenstein, Oliver, et al.
  Udgivet: (2010)
• A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR
  af: Dupoiron, D., et al.
  Udgivet: (2017)
• Long‐term efficacy and safety of oxycodone‐naloxone prolonged‐release formulation (up to 180/90 mg daily) – results of the open‐label extension phase of a phase III multicenter, multiple‐dose, randomized, controlled study
  af: Dupoiron, D., et al.
  Udgivet: (2017)
• Pain therapy with oxycodone/naloxone prolonged-release combination: case report
  af: Błaszczyk, Feliks, et al.
  Udgivet: (2013)